- Home
- RPRX vs JKHY Comparison
RPRX vs JKHY Comparison
Compare RPRX & JKHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- JKHY
- Stock Information
- Founded
- RPRX 1996
- JKHY 1976
- Country
- RPRX United States
- JKHY United States
- Employees
- RPRX N/A
- JKHY N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- JKHY Retail: Computer Software & Peripheral Equipment
- Sector
- RPRX Health Care
- JKHY Technology
- Exchange
- RPRX Nasdaq
- JKHY Nasdaq
- Market Cap
- RPRX 15.6B
- JKHY 12.6B
- IPO Year
- RPRX 2020
- JKHY N/A
- Fundamental
- Price
- RPRX $35.87
- JKHY $163.26
- Analyst Decision
- RPRX Strong Buy
- JKHY Hold
- Analyst Count
- RPRX 3
- JKHY 10
- Target Price
- RPRX $45.33
- JKHY $184.70
- AVG Volume (30 Days)
- RPRX 3.1M
- JKHY 842.8K
- Earning Date
- RPRX 08-06-2025
- JKHY 08-19-2025
- Dividend Yield
- RPRX 2.45%
- JKHY 1.42%
- EPS Growth
- RPRX 54.86
- JKHY 19.31
- EPS
- RPRX 2.32
- JKHY 6.24
- Revenue
- RPRX $2,305,243,000.00
- JKHY $2,375,288,000.00
- Revenue This Year
- RPRX $33.77
- JKHY $7.48
- Revenue Next Year
- RPRX $4.62
- JKHY $6.38
- P/E Ratio
- RPRX $15.45
- JKHY $26.09
- Revenue Growth
- RPRX 3.02
- JKHY 7.21
- 52 Week Low
- RPRX $24.05
- JKHY $157.80
- 52 Week High
- RPRX $38.00
- JKHY $196.00
- Technical
- Relative Strength Index (RSI)
- RPRX 42.45
- JKHY 43.98
- Support Level
- RPRX $35.48
- JKHY $161.86
- Resistance Level
- RPRX $36.99
- JKHY $163.15
- Average True Range (ATR)
- RPRX 0.68
- JKHY 2.97
- MACD
- RPRX -0.14
- JKHY 0.69
- Stochastic Oscillator
- RPRX 7.28
- JKHY 60.23
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About JKHY Jack Henry & Associates Inc.
Jack Henry is a leading provider of core processing and complementary services, such as electronic funds transfer, payment processing, and loan processing for US banks and credit unions, with a focus on small and midsize banks. Jack Henry serves almost 1,000 banks and over 700 credit unions.